These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 3907577

  • 21. Review of experimental hyaline membrane disease.
    Robertson B.
    Diagn Histopathol; 1981; 4(1):49-60. PubMed ID: 7018865
    [Abstract] [Full Text] [Related]

  • 22. The effects of surfactant on haemodynamics in hyaline membrane disease.
    Skinner J.
    Arch Dis Child Fetal Neonatal Ed; 1997 Mar; 76(2):F67-9. PubMed ID: 9135282
    [No Abstract] [Full Text] [Related]

  • 23. [Factors increasing susceptibility to neonatal hyaline membrane syndrome and its prevention. I. Deficiency of surfactant and glucocorticoid treatment].
    Uszyńska-Folejewska R, Uszyński M.
    Pediatr Pol; 1977 Dec; 52(12):1413-7. PubMed ID: 343058
    [No Abstract] [Full Text] [Related]

  • 24. The effectiveness and cost of exogenous pulmonary surfactant replacement therapy.
    Smith J, Pieper C, Gie RP.
    S Afr Med J; 1995 Nov; 85(11):1192, 1195-6. PubMed ID: 8597017
    [No Abstract] [Full Text] [Related]

  • 25. Endotracheal continuous positive airway pressure after rescue surfactant therapy.
    Mandy GT, Moïse AA, Smith EO, Hansen TN.
    J Perinatol; 1998 Nov; 18(6 Pt 1):444-8. PubMed ID: 9848758
    [Abstract] [Full Text] [Related]

  • 26. Surfactant replacement therapy.
    Kresch MJ, Lin WH, Thrall RS.
    Thorax; 1996 Nov; 51(11):1137-54. PubMed ID: 8958900
    [No Abstract] [Full Text] [Related]

  • 27. Neonatal surfactant replacement therapy. Fetus and Newborn Committee, Canadian Paediatric Society.
    CMAJ; 1992 Apr 15; 146(8):1309-12. PubMed ID: 1555161
    [No Abstract] [Full Text] [Related]

  • 28. Surfactant replacement in spontaneously breathing babies with hyaline membrane disease--a pilot study.
    Victorin LH, Deverajan LV, Curstedt T, Robertson B.
    Biol Neonate; 1990 Apr 15; 58(3):121-6. PubMed ID: 2279046
    [Abstract] [Full Text] [Related]

  • 29. Hyaline membrane disease (HMD) therapy in Latin America: impact of exogenous surfactant administration on newborn survival, morbidity and use of resources.
    Rossello JD, Hayward PE, Martell M, Del Barco M, Margotto P, Grandzoto J, Bastida J, Peña J, Villanueva D.
    J Perinat Med; 1997 Apr 15; 25(3):280-7. PubMed ID: 9288665
    [Abstract] [Full Text] [Related]

  • 30. [Letter: Hyaline membrane disease. Hyaline membrane and neonatal respiratory pathology].
    Jejeune JA, Huault G.
    Nouv Presse Med; 1974 Oct 26; 3(36):2338. PubMed ID: 4480380
    [No Abstract] [Full Text] [Related]

  • 31. Surfactant treatment in experimental hyaline membrane disease.
    Nilsson R, Grossmann G, Berggren P, Robertson B.
    Eur J Respir Dis; 1981 Dec 26; 62(6):441-9. PubMed ID: 6922790
    [Abstract] [Full Text] [Related]

  • 32. Biochemical basis of hyaline membrane disease.
    Forman DT.
    Ann Clin Lab Sci; 1973 Dec 26; 3(4):242-8. PubMed ID: 4740424
    [No Abstract] [Full Text] [Related]

  • 33. Newer strategies in the prevention of hyaline membrane disease.
    Willett LD.
    Nebr Med J; 1994 Aug 26; 79(8):303-4. PubMed ID: 7990997
    [No Abstract] [Full Text] [Related]

  • 34. [High-frequency oscillatory lung ventilation in complex therapy for congenital pneumonia and hyaline membrane disease in newborns].
    Antonov AG, Ionov OV, Burkova AS.
    Anesteziol Reanimatol; 2005 Aug 26; (1):41-4. PubMed ID: 15839224
    [Abstract] [Full Text] [Related]

  • 35. Hyaline membrane disease: future treatment modalities.
    Richardson C.
    J Perinat Neonatal Nurs; 1988 Jul 26; 2(1):78-88. PubMed ID: 3379615
    [No Abstract] [Full Text] [Related]

  • 36. Cellular and biochemical aspects of pulmonary surfactant in health and disease.
    Kikkawa Y, Smith F.
    Lab Invest; 1983 Aug 26; 49(2):122-39. PubMed ID: 6348405
    [No Abstract] [Full Text] [Related]

  • 37. The effects of surfactant and antenatal corticosteroid treatment on the pulmonary pathology of preterm infants with respiratory distress syndrome.
    Teksam O, Kale G.
    Pathol Res Pract; 2009 Aug 26; 205(1):35-41. PubMed ID: 18951732
    [Abstract] [Full Text] [Related]

  • 38. The pulmonary surfactant.
    Sekabunga JG.
    East Afr Med J; 1973 Jan 26; 50(1):27-32. PubMed ID: 4578486
    [No Abstract] [Full Text] [Related]

  • 39. [Importance of the "surfactant system" in the pathogenesis of hyaline membrane in the newborn].
    Cosmi EV, Condorelli S, Scarpelli EM.
    Acta Anaesthesiol; 1970 Jan 26; 31():Suppl:69-94. PubMed ID: 5538013
    [No Abstract] [Full Text] [Related]

  • 40. Surfactant replacement therapy. Innovative care for the premature infant.
    Miller EP, Armstrong CL.
    J Obstet Gynecol Neonatal Nurs; 1990 Jan 26; 19(1):14-7. PubMed ID: 2299437
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.